AACR 2024: How cellular plasticity drives cancer metastasis
About 90% of deaths from cancer are a result of metastasis — that is, from…
Browsing: AACR
AACR 2024: Proteogenomic signatures may help identify risk of prostate cancer progression in patients with African and European ancestries
Certain proteogenomic signatures in the prostate cancers of men of African and European ancestries were…
AACR 2024: Investigational personalised vaccine provides clinical benefit for some patients with resected head and neck cancers
TG4050, a personalised neoantigen vaccine, induced tumour-specific immune responses and led to low rates of…
AACR 2024: Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer
A blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of…
AACR 2024: AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma in phase I trial
AZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both…
AACR 2024: An exosome-based liquid biopsy shows promise for early detection of pancreatic cancer
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined…
AACR 2024: Linvoseltamab shows high response rate in heavily pre-treated multiple myeloma
The Phase 1/2 LINKER-MM1 trial of linvoseltamab in patients with relapsed/refractory (R/R) multiple myeloma (MM)…
AACR 2024: Researchers show oestrogen metabolites contribute to development of lung cancer among people who never smoked
In a study presented today at the American Association for Cancer Research (AACR) Annual Meeting…
AACR 2024: Culturally sensitive video targeting Black men may help increase awareness about prostate cancer
A video designed to educate Black men about prostate cancer resulted in 97% of surveyed participants…
AACR 2024: Adagrasib plus cetuximab may provide clinical benefit in patients with KRASG12c-mutated colorectal cancer
A combination of the KRASG12C inhibitor adagrasib and the anti-epidermal growth factor receptor (EGFR) antibody…